Cognition Therapeutics Inc.

Discovering small molecule therapeutics for Alzheimer's and other neurodegenerative diseases

Cognition Therapeutics, Inc. is a drug discovery company developing small molecule therapeutics that block the protein oligomers responsible for Alzheimer’s disease. These oligomers interfere with molecular memory mechanisms at the earliest stages of neurodegenerative disease. Located in Pittsburgh’s historic South Side, we are seeking highly motivated individuals to work in a dynamic start-up company environment.

Research Scientist, Neurobiology

The candidate will be a key contributor in a scientific research team developing cutting-edge cell-based assays. Responsibilities include assay development using primary neuronal cultures, compound library screen execution and statistical data analysis, and studies of compound mechanism of action. The candidate will work with others in a team-based environment and make formal presentations of experimental results to the company.

Qualifications

· Ph.D. in neurobiology, industry experience a plus

· Background in learning and memory biology, neurodegenerative disease biology

· Technical expertise in primary neuronal cultures, immunohistochemistry, westerns, ELISAs, microscopy, automated imaging with Cellomics VTI platform.

Please send your resume and references to: info@cogrx.com

Cognition Therapeutics, Inc. is an equal opportunity employer.

COgnition THerapeutics welcomes inquiries from potential investors

Please contact Hank Safferstein at 412.770.1621

For more information on Alzheimer’s patient care, go to the Alzheimer Research Forum website